GLENMARK PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

23 Mar 2020

Glenmark Pharmaceuticals receives ANDA tentative approval for Dapagliflozin Tablets, 5 mg and 10 mg

Source: BSE India

View all announcements for GLENMARK PHARMACEUTICALS LTD.